Impact of Treatment Free Remission (TFR) with Nilotinib in 2nd Line for Chronic Myeloid Leukemia on Savings That May Fund All BCR-ABL Tests in the Brazilian Public Healthcare System during and after Nilotinib Treatment

Please use this identifier to cite or link to this item: https://observatorio.fm.usp.br/handle/OPI/31348

Title:	Impact of Treatment Free Remission (TFR) with Nilotinib in 2nd Line for Chronic Myeloid Leukemia on Savings That May Fund All BCR-ABL Tests in the Brazilian Public Healthcare System during and after Nilotinib Treatment
Authors:	ABDO, Andre; BOQUIMPANI, Carla Maria; VIVONA, Douglas; LEITE, Viviane Silveira; MATSUO, Alisson L.; TEICH, Vanessa; BENDIT, Israel; REGO, Eduardo Magalhaes; ROCHA, Vanderson
Citation:	BLOOD, v.132, suppl.1, 2018
Appears in Collections:	Comunicações em Eventos - FM/MCM Departamento de Clínica Médica - FM/MCM Comunicações em Eventos - HC/ICESP Instituto do Câncer do Estado de São Paulo - HC/ICESP Comunicações em Eventos - HC/ICHC Instituto Central - HC/ICHC Comunicações em Eventos - LIM/31 LIM/31 - Laboratório de Genética e Hematologia Molecular

Files in This Item:

There are no files associated with this item.